Paper34720161
Comparison of Ceftriaxone and Antipseudomonal β-Lactam Antibiotics Utilized for Potential AmpC β-Lactamase-Producing Organisms.
Peters DM and 4 others. Hosp Pharm, 2021. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Comparison of Ceftriaxone and Antipseudomonal β-Lactam Antibiotics Utilized for Potential AmpC β-Lactamase-Producing Organisms. Papers, record 34720161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34720161
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of Ceftriaxone and Antipseudomonal β-Lactam Antibiotics Utilized for Potential AmpC β-Lactamase-Producing Organisms.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11502540 | Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11502540 | PubMed |
| 2 | 30602511 | Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance? | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30602511 | PubMed |
| 3 | 7962982 | Epidemiology of nosocomial infections in adult intensive care units. | Intensive Care Med | 1994 | https://conductscience.org/library/papers/7962982 | PubMed |
| 4 | 3305004 | Development of resistance during antibiotic therapy. | Eur J Clin Microbiol | 1987 | https://conductscience.org/library/papers/3305004 | PubMed |
| 5 | 7667163 | Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. | Pharmacotherapy | 1995 | https://conductscience.org/library/papers/7667163 | PubMed |
| 6 | 19952319 | International study of the prevalence and outcomes of infection in intensive care units. | JAMA | 2009 | https://conductscience.org/library/papers/19952319 | PubMed |
| 7 | 28979397 | Pharmacokinetic considerations and dosing strategies of antibiotics in the critically ill patient. | J Intensive Care Soc | 2015 | https://conductscience.org/library/papers/28979397 | PubMed |
| 8 | 19136439 | AmpC beta-lactamases. | Clin Microbiol Rev | 2009 | https://conductscience.org/library/papers/19136439 | PubMed |
| 9 | 20805405 | Origins and evolution of antibiotic resistance. | Microbiol Mol Biol Rev | 2010 | https://conductscience.org/library/papers/20805405 | PubMed |
| 10 | 14706093 | Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae? | Clin Microbiol Infect | 2004 | https://conductscience.org/library/papers/14706093 | PubMed |
| 11 | 30208454 | Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. | JAMA | 2018 | https://conductscience.org/library/papers/30208454 | PubMed |
| 12 | 8723487 | Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. | Antimicrob Agents Chemother | 1996 | https://conductscience.org/library/papers/8723487 | PubMed |
| 13 | 30061284 | Past and Present Perspectives on β-Lactamases. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/30061284 | PubMed |
| 14 | 6109327 | The structure of beta-lactamases. | Philos Trans R Soc Lond B Biol Sci | 1980 | https://conductscience.org/library/papers/6109327 | PubMed |
| 15 | 1892329 | Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. | Ann Intern Med | 1991 | https://conductscience.org/library/papers/1892329 | PubMed |
| 16 | 30506852 | Duration of Exposure to Antipseudomonal β-Lactam Antibiotics in the Critically Ill and Development of New Resistance. | Pharmacotherapy | 2019 | https://conductscience.org/library/papers/30506852 | PubMed |
| 17 | 29444952 | Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae. | Clin Microbiol Rev | 2018 | https://conductscience.org/library/papers/29444952 | PubMed |
| 18 | 12519358 | Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation. | Clin Microbiol Infect | 2002 | https://conductscience.org/library/papers/12519358 | PubMed |
| 19 | 19237886 | Pharmacokinetic issues for antibiotics in the critically ill patient. | Crit Care Med | 2009 | https://conductscience.org/library/papers/19237886 | PubMed |
| 20 | 12516026 | Bacterial resistance: origins, epidemiology, and impact. | Clin Infect Dis | 2003 | https://conductscience.org/library/papers/12516026 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40205142 | Characteristics and Outcomes of Patients Treated with Carbapenem Versus Non-carbapenem Therapy for AmpC-Producing Enterobacterales Bacteremia: A Retrospective Study. | Infect Dis Ther | 2025 | https://conductscience.org/library/papers/40205142 | PubMed |
| 35811614 | Recent advances in quantum dots-based biosensors for antibiotics detection. | J Pharm Anal | 2022 | https://conductscience.org/library/papers/35811614 | PubMed |
| 34543093 | Incidence and Predictors of Gram-Negative Bacilli in Hospitalized People Who Inject Drugs with Injection Drug Use-Attributable Infections. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/34543093 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34720161
GET https://conductscience.org/api/papers/v1/34720161/references?page=2